Method for screening for an antiviral agent, by determining whether a potential agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus RNA compared to a host RNA under virus infection conditions; and determining whether any interaction of the agent with the component reduces the level of translation of an RNA of the virus.

 
Web www.patentalert.com

< Pyrazolopyridine derivates

> HCV NS5B inhibitors

~ 00466